Power Lung Versus Acapella After Coronary Artery Bypass Graft Surgery

NCT ID: NCT05260944

Last Updated: 2023-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-05

Study Completion Date

2023-08-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to compare between the power lung versus acapella on airway clearance after coronary artery bypass graft surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this part of the study the materials and methods will be presented under the following headings: subjects, equipments, procedures of the study and statistical procedures

1. Subjects. Ninty patients of both sexes will participate in this study with an age range of 40 to 50 years old. They will be chosen from outpatient clinic, Qena University Hospital.

Patients will be randomely assigned into three groups:

Group A: patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

Group B: patients will receive a two supervised session using power lung device three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration).

Group C. Patients will receive only routine physical Therapy program.
2. Equipment:

1\. For evaluation: Arterial blood gases including: - paO2, paCO2, PH and O2 saturation. Spirometry measurements: - as forced vital capacity (FVC) andbforced expiratory volume in the first second (FEV1).

The incidence of PPCs and the length of postoperative stay: - using the Melbourne Group Scale Dyspnea. According to the revised or modified Borg scale or rating of perceived exersion.

The Rand SF 36 health survey questionnaire. 2. For treatment The power lung device. Acapella device.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Bypass Graft Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

In the study three groups of patients will participated first, group A. Will receive acapella device.

Second, group B. Will receive power lung device. Third, group C. Will receive only routine physical Therapy program.
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators
The participants are the patients who undergoing coronary artery bypass graft surgery.

The care providers are the cardiothoraci surgeon and the nursing staff. The investigator is the physical Therapy ( my self)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Group A. Thirty patients will receive a two supervised session using Acapella three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration).

Group Type EXPERIMENTAL

Acapella device

Intervention Type DEVICE

patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

Group B

Thirty patients will receive a two supervised sessions using power lung device three sets for 10 repetitions from the first day postoperative until 7 days(André L.et al., 2016), in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration).

Group Type EXPERIMENTAL

Power lung device

Intervention Type DEVICE

Group B. patients will receive a two supervised sessions using power lung device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

Group C

Thirty patients will receive only routine physical Therapy program.

Group Type ACTIVE_COMPARATOR

routine Physical Therapy program

Intervention Type OTHER

Group C. Thirty patients will receive only routine physical Therapy program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acapella device

patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

Intervention Type DEVICE

Power lung device

Group B. patients will receive a two supervised sessions using power lung device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

Intervention Type DEVICE

routine Physical Therapy program

Group C. Thirty patients will receive only routine physical Therapy program

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* They will be from 40-50 years old.
* They will be patients undergo elective CABG surgery.
* Non productive cough postoperatively.
* Cough pain intensity \> 5 as rated on a visual analogue scale (VAS) on postoperative day 1.

Exclusion Criteria

* Patients with chronic chest diseases.
* Patients with an intensive postoperative care (ICU) stay \> 48 hrs.
* Uncooperative patients.
Minimum Eligible Age

40 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

South Valley University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shymaa yussuf abo zaid

Assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shymaa Y Abo zaid, Master

Role: PRINCIPAL_INVESTIGATOR

Assistant lecturer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shymaa yussuf abo zaid

Qina, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/002682

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.